Rejuvenating aging

What anti-aging company Juvenescence plans to do with its series A

Anti-aging company Juvenescence Ltd. is hoping to bring a total of 10 candidates from its portfolio companies and academic partnerships into the clinic over the next two years with its recent $50 million series A funding.

Announced on June 11, the oversubscribed financing saw participation from company founders and insiders, as well as undisclosed

Read the full 544 word article

User Sign In